Fluoroquinolones, the commonly used antibacterials, have been associated with dysglycemia (hypoglycemia and/or hyperglycemia) mainly in patients with diabetes taking either oral hypoglycemic agents or insulin [1]. This evidence concerns the gene INS and Hypoglycemia.